Physician profile
Daranee Chewaproug
NPI 1285884825
$1,528.12
in general payments reported to CMS, 2019-2025
19 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.77 · 2020: $56.12 · 2021: $45.15 · 2022: $151 · 2023: $172 · 2024: $522 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $204.49 | 2024-2025 | |
| Ardelyx, INC. | $196.19 | 2024-2025 | Ibsrela |
| Astrazeneca Pharmaceuticals LP | $146.57 | 2020-2023 | Farxiga |
| Amgen INC. | $126.44 | 2023-2025 | Tavneos, Parsabiv |
| Akebia Therapeutics INC | $100.17 | 2019-2025 | Vafseo |
| Vifor Pharma, INC. | $99.57 | 2019-2025 | Veltassa, Korsuva |
| Calliditas Therapeutics US INC. | $93.36 | 2025 | Tarpeyo |
| Bayer Healthcare Pharmaceuticals INC. | $78.10 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $71.69 | 2024-2025 | Jynarque |
| Fresenius USA Marketing, INC. | $59.02 | 2022-2023 | Velphoro |
| Aurinia Pharma U.S., INC. | $57.21 | 2022-2024 | Lupkynis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.25 | 2024-2025 | Jardiance |
| Kyowa Kirin, INC. | $54.30 | 2024-2025 | Crysvita |
| Glaxosmithkline, LLC. | $40.38 | 2022-2023 | Jesduvroq, Benlysta |
| Travere Therapeutics, INC. | $38.57 | 2024-2025 | Filspari |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leadiant Biosciences, INC. | $37.73 | 2023 | Carnitor |
| Mallinckrodt Hospital Products INC. | $36.69 | 2024 | Acthar |
| Baxter Healthcare | $17.94 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $13.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daranee Chewaproug listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.